PARIS (Reuters) - France is looking to sell millions of surplus vaccines for the H1N1 flu strain after ordering many more shots than it actually needed, officials said on Sunday.
The Health Ministry said in a statement it had originally bought 94 million individual vaccinations against the H1N1 virus at a cost of 869 million euros ($1.25 billion), thinking that everyone would need two jabs for immunity against the illness.
Doctors now say a single vaccination is sufficient, meaning that France, with a population of some 65 million, has a massive oversupply that it is looking to sell on.
France wants to sell millions of surplus flu shots | Reuters
The Health Ministry said in a statement it had originally bought 94 million individual vaccinations against the H1N1 virus at a cost of 869 million euros ($1.25 billion), thinking that everyone would need two jabs for immunity against the illness.
Doctors now say a single vaccination is sufficient, meaning that France, with a population of some 65 million, has a massive oversupply that it is looking to sell on.
France wants to sell millions of surplus flu shots | Reuters
